Banzel Tablet, Film Coated
Product Images NDC 62856-583

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Banzel (NDC 62856-583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eisai Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Banzel (rufinamide) (Banzel 01)

Chemical structure of rufinamide, the active ingredient in Banzel tablets. The diagram shows the molecular arrangement including fluorine atoms and an amide group characteristic of this compound.*

FDA Label Image

Tablet Imprint (Banzel 02)

Banzel 200 mg film-coated tablets blister pack. The label shows the brand name 'Banzel' with the active ingredient rufinamide. The package contains multiple round tablets arranged in a blister card format. Manufactured by Eisai Inc.*

FDA Label Image

Figure A (Banzel 03)

An instructional illustration showing a bottle with a cap, a box, a bottle adapter, and two syringes marked with measurement units. The diagram labels each item, depicting components likely related to medication preparation or administration.*

FDA Label Image

Figure B (Banzel 04)

An instructional illustration showing a hand holding a bottle with arrows indicating to shake the bottle well before use.*

FDA Label Image

Figure C (Banzel 05)

An illustration of a bottle adapter labeled with an arrow pointing to it. The image appears to show the structure or design of a bottle adapter component.*

FDA Label Image

Figure D (Banzel 06)

An illustration depicting a hand holding a bottle, showing the action of pressing down on the cap, indicated by a downward arrow. This likely demonstrates how to open or close the bottle cap.*

FDA Label Image

Figure E (Banzel 07)

An instructional diagram showing a syringe with volume markings in milliliters from 5 mL to 20 mL, highlighting the plunger. The image focuses on the proper use or measurement technique related to an oral liquid pharmaceutical product.*

FDA Label Image

Figure F (Banzel 08)

An instructional illustration showing a hand holding a syringe above a bottle with a downward arrow, indicating the syringe is to be inserted or used with the bottle. No text or branding is visible.*

FDA Label Image

Figure G (Banzel 09)

An instructional illustration showing a hand holding a dosing syringe filled with liquid medication, with an arrow indicating the direction to push or operate the syringe.*

FDA Label Image

Figure H (Banzel 0a)

Illustration showing a person using a syringe to measure liquid medicine to the white end of the plunger, indicating proper measurement technique for accurate dosing.*

FDA Label Image

Figure I (Banzel 0b)

An instructional illustration showing a person administering oral medication using a syringe. The syringe is positioned at the person's mouth, demonstrating the method for oral dosing.*

FDA Label Image

Figure J (Banzel 0c)

An instructional illustration showing a hand holding a syringe above a container of liquid. The left side depicts drawing liquid into the syringe by pulling the plunger up, indicated by an upward arrow. The right side shows expelling liquid from the syringe by pressing the plunger down, indicated by a downward arrow.*

FDA Label Image

Figure K (Banzel 0d)

An instructional illustration showing a hand removing the cap from a bottle, indicating how to open the bottle closure.*

FDA Label Image

Principal Display Panelndc 62856-582-04banzel® (rufinamide) Tablets200 mg4 Tablets (Banzel 0e)

Label for Banzel (rufinamide) 200 mg film-coated tablets by Eisai Inc. The label includes storage instructions, dosage and use directions referencing prescribing information, and an attention box to dispense with the medication guide. The package contains 120 tablets and is made in Belgium. The label includes a barcode and a non-varnish lot/expiration serialization area.*

FDA Label Image

Principal Display Panelndc 62856-582-52banzel® (rufinamide) Tablets200 mg120 Tablets (Banzel 0f)

Banzel 400 mg film-coated tablets label showing product name, generic name rufinamide, strength 400 mg, and package count of 120 tablets. Label includes storage instructions, dosage reminder, and Eisai Inc. as the labeler. Barcode and serialization area are also visible.*

FDA Label Image

Principal Display Panelndc 62856-583-14banzel®(rufinamide) Tablets400 mg14 Tablets (Banzel 10)

Banzel (rufinamide) oral suspension 40 mg/mL in a 460 mL bottle label. The label specifies it is for oral administration only, with instructions to shake well before use. It is a prescription drug distributed by Eisai Inc., with storage information and usage cautions noted.*

FDA Label Image

Principal Display Panelndc 62856-583-52banzel®(rufinamide) Tablets400 mg120 Tablets (Banzel 11)

Packaging label for Banzel (rufinamide) oral suspension, 40 mg/mL, 460 mL bottle. The label includes dosage instructions, storage conditions, and a warning to dispense with enclosed medication guide. Manufactured by Eisai Inc. The label design uses purple and green colors and features a barcode and NDC number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.